Immunomodulator-induced resistance against herpes simplex virus.
D000818:Animals; D000831:Animals, Newborn / Q000276:immunology; D005260:Female; D006003:Glycogen / Q000627:therapeutic use; D006561:Herpes Simplex / Q000276:immunology / Q000382:microbiology / Q000517:prevention & control*; D007978:Levamisole / Q000627:therapeutic use; D008264:Macrophages / Q000187:drug effects / Q000276:immunology; D051379:Mice; D011425:Propionibacterium acnes / Q000276:immunology*; D011714:Pyrans / Q000627:therapeutic use*; D012822:Silicon Dioxide / Q000633:toxicity; D018139:Simplexvirus / Q000254:growth & development; D014611:Vaccination; D014627:Vaginitis / Q000276:immunology / Q000382:microbiology / Q000517:prevention & control*
D011714:Pyrans; D007978:Levamisole; D012822:Silicon Dioxide; D006003:Glycogen